Performance
5 Days
0 0%
1 Month
0 0%
3 Months
0 0%
6 Months
0 0%
1 Year
0 0%
2 Year
0 0%
Key data
Company detail
CEO:
Region: US
Website: clarustherapeutics.com
Employees: 2
IPO year: -
Issue type:
Market: NASDAQ
Industry:
Sector:
Region: US
Website: clarustherapeutics.com
Employees: 2
IPO year: -
Issue type:
Market: NASDAQ
Industry:
Sector:
Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women – including potential therapies for orphan indications. Clarus Therapeutics’ first commercial product is JATENZO®.
Recent news